These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2309243)

  • 1. Cisplatin nephrotoxicity in lead-pretreated rats: enzymatic and morphological studies.
    Bompart G; Orfila C
    Toxicol Lett; 1990 Feb; 50(2-3):237-47. PubMed ID: 2309243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin nephrotoxicity in cadmium-pretreated rats. Enzymatic, functional and morphological studies.
    Bompart G; Orfila C; Manuel Y
    Nephron; 1991; 58(1):68-74. PubMed ID: 1857484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced changes in cytochrome P-450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex.
    Bompart G
    Toxicol Lett; 1989 Aug; 48(2):193-9. PubMed ID: 2772925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY; Al-Rikabi AC
    Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation.
    Sahu BD; Kuncha M; Putcha UK; Sistla R
    Exp Toxicol Pathol; 2013 Sep; 65(6):933-40. PubMed ID: 23395153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloroplatinum (II).
    Laurent G; Yernaux V; Nonclercq D; Toubeau G; Maldague P; Tulkens PM; Heuson-Stiennon JA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(3):129-45. PubMed ID: 2899921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced changes on cytochrome P-450, lipid peroxidation and some P-450 related specific catalytic activities in rat liver.
    Bompart G
    J Toxicol Clin Exp; 1990 Oct; 10(6):375-83. PubMed ID: 2130181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats.
    al-Harbi MM; Osman AM; al-Gharably NM; al-Bekairi AM; al-Shabanah OA; Sabah DM; Raza M
    Chemotherapy; 1995; 41(6):448-54. PubMed ID: 8529435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of immunoreactive EGF and EGF receptor after acute tubular necrosis induced by tobramycin or cisplatin.
    Leonard I; Zanen J; Nonclercq D; Toubeau G; Heuson-Stiennon JA; Beckers JF; Falmagne P; Schaudies RP; Laurent G
    Ren Fail; 1994; 16(5):583-608. PubMed ID: 7855315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-nephrotoxic cisplatin sensitizes rats to acute renal failure and increases urinary excretion of fumarylacetoacetase.
    Vicente-Vicente L; Sánchez-Juanes F; García-Sánchez O; Blanco-Gozalo V; Pescador M; Sevilla MA; González-Buitrago JM; López-Hernández FJ; López-Novoa JM; Morales AI
    Toxicol Lett; 2015 Apr; 234(2):99-109. PubMed ID: 25677510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lipid peroxidation in the nephrotoxicity of cisplatin.
    Vermeulen NP; Baldew GS
    Biochem Pharmacol; 1992 Sep; 44(6):1193-9. PubMed ID: 1417941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of lipid oxidation markers, N(ε)-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats.
    Sugiyama A; Sun J; Nishinohara M; Fujita Y; Masuda A; Ochi T; Takeuchi T
    J Vet Med Sci; 2011 Jun; 73(6):821-6. PubMed ID: 21258181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis.
    Francescato HD; Coimbra TM; Costa RS; Bianchi Mde L
    Kidney Blood Press Res; 2004; 27(3):148-58. PubMed ID: 15118361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity.
    Fillastre JP; Raguenez-Viotte G
    Toxicol Lett; 1989 Mar; 46(1-3):163-75. PubMed ID: 2650023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology.
    Vickers AE; Rose K; Fisher R; Saulnier M; Sahota P; Bentley P
    Toxicol Pathol; 2004; 32(5):577-90. PubMed ID: 15603542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minireview. The nephrotoxicity of cisplatin.
    Goldstein RS; Mayor GH
    Life Sci; 1983 Feb; 32(7):685-90. PubMed ID: 6338333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage.
    Sahu BD; Kuncha M; Sindhura GJ; Sistla R
    Phytomedicine; 2013 Mar; 20(5):453-60. PubMed ID: 23353054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats.
    Sadzuka Y; Shoji T; Takino Y
    Toxicol Lett; 1992 Sep; 62(2-3):293-300. PubMed ID: 1412515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.